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INTRODUCTION
Brain metastases occur in 25–35% of all cancer patients, 
often leading to debilitating neurologic symptoms and 
contributing to a worse overall prognosis.[16] Lung cancer 
is the malignancy that most commonly metastasizes to 
the brain (35%), followed by breast cancer (21%), kidney 
cancer, gastrointestinal cancer, and melanoma.[19] Median 
survival after diagnosis of a brain lesion is approximately 1 
year if maximal treatment measures (surgery, radiotherapy, 
chemotherapy) are undertaken.[19] This decreases to 6–12 
months in patients with multiple metastatic lesions.[19] 
For multiple brain metastases, whole-brain radiation 
therapy (WBRT) is usually the treatment of choice; 
however, surgical resection of a solitary brain metastatic 
lesion followed by WBRT has been shown to increase 
the median survival to 14 months from 9 months with 
WBRT alone.[14,15] With new advancements in the 
diagnosis and treatment of various types of cancer, 
the reported incidence of brain metastases is likely to 
increase, accompanied by increasing length of patient 
survival.[1] This will require that neurosurgical oncologists 
have more techniques at their disposal for safely and 
effectively managing these patients. Intraoperative 
guidance techniques such as frameless stereotaxy using 
preoperative brain magnetic resonance images have been 
shown to prolong survival time in patients with single 
or multiple cerebral metastases.[19] Neuronavigation 
facilitates a less invasive approach to tumor resection, 
which is attractive in patients with metastatic disease 
who are often physically debilitated. In this review, 
we will focus on the patient selection, tumor location 
and selection, intraoperative technique, advantages, 
disadvantages, and outcomes associated with the use of 
image guidance in the resection of cerebral metastases. 
PATIENT SELECTION
In the senior author’s (RLJ) practice, patients with 
metastatic disease are treated with various modalities 
for management of their intracranial disease [Table 1]. 
Increasingly, stereotactic radiosurgery (SRS) has become a 








The primary goal in removing a metastatic brain tumor is to maximize surgical 
resection while minimizing the risk of neurological injury. Intraoperative image 
guidance is frequently used in the resection of both primary and metastatic brain 
tumors. Stereotactic volumetric techniques allow for smaller craniotomies, facilitate 
lesion localization, and help neurosurgeons avoid eloquent structures. In turn, this 
leads to decreased patient morbidity and shorter hospitalizations. Image guidance 
is not without shortcomings, however, perhaps the most significant of which is 
inaccuracy of tumor resection associated with intraoperative brain shifts. The goal 
of this review is to expound on the uses of image guidance and discuss avoidance 
of technical pitfalls in the resection of cerebral metastatic lesions.
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mainstay treatment for patients with limited intracranial 
disease. The outcomes from large series of patients 
treated with SRS, including our own, are really quite 
good.[4,5,9,17,18] In many ways, this has raised the bar for 
expectations of outcomes for treatment of intracranial 
brain metastasis. SRS has a high rate of local control 
and low complication rate. Thus, any surgical series must 
demonstrate similar outcomes, which neuronavigation 
can facilitate.
The role of surgical resection in the management of 
intracranial disease became widely accepted with the 
publication in 1990 of the seminal paper by Patchell 
et al.,[15] which demonstrated that surgery followed 
by WBRT was superior to WBRT alone for patients 
with a single brain metastasis. Although this paper 
focused on single metastatic brain lesions, the data 
from this study have provided valuable guidance 
regarding patient selection. First and foremost, we see 
that not all patients with brain metastases will benefit 
from surgical intervention. Traditional indications for 
operating on patients with cerebral metastases include 
young patients with surgically accessible, symptomatic 
lesions and a Karnofsky performance score (KPS) ≥70.[21] 
Other indications include patients with an undiagnosed 
primary tumor with the need for confirmation of tissue 
histology or for immediate tumor decompression due 
to life-threatening neurologic symptoms and likelihood 
of a long disease-free interval after surgical resection. 
Historically, patients with multiple brain metastases were 
thought not to be good surgical candidates because of 
their poor overall prognosis;[21] however, with the advent 
of image guidance and intraoperative neuronavigation, 
sick patients with multiple symptomatic lesions can 
benefit from smaller, more precise craniotomies and no 
longer need to be excluded from surgical consideration. 
Therefore, the decision on whether to operate for 
resection of a metastatic lesion should be based on 
patient age, KPS, number and location of metastatic 
lesions, symptomatology, need for tissue diagnosis, and 
overall prognosis. 
ADVANTAGES OF IMAGE GUIDANCE
Despite initial resistance by many experienced 
neurosurgeons, the use of image guidance and 
neuronavigation has become standard in the resection 
of metastatic brain lesions.[6,7] This is largely because of 
more precise cranial localization, surgical planning, tumor 
identification, and accuracy, which have been shown 
to decrease patient morbidity as well as lead to shorter 
inpatient hospital stays.[13]


















IMRI SRS Gliasite 
balloon 
brachytherapy
Melanoma 198 316 7 69 4 236 4
Lung 110 137 7 55 1 84
Breast 97 133 4 36 1 92
Renal 51 79 1 19 1 59 2
Colon/rectal 10 12 3 5 3 1
Sarcoma 22 27 2 14 11
Esophageal 7 14 3 6 3 2
Squamous cell 11 7 2 5
Ovarian 10 15 5 10
Endometrial 4 6 3 3
Prostate 4 5 3 2
Bladder 2 2 1 1 1 1
Thyroid 9 10 2 8
Neuroendocrine 2 3 2 1 1
Salivary gland 2 3 1 2
Sinonasal 1 1 1
Seminoma 1 1 1
Unknown 5 10 6 1 4
Total 546 781 28 231 9 2 524 9
IMRIS: Intraoperative magnetic resonance imaging, SRS: Stereotactic radiosurgery
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Dating back to the days of the eminent neurologist 
Paul Broca, the quest for cerebral localization has 
proved difficult. In more modern times, even in the 
hands of the most experienced neurosurgeons, finding 
intracranial targets can be challenging. This is especially 
true in smaller lesions or those near eloquent cortex, 
as illustrated by a simple case example. A 67-year-old 
man with a history of renal cell carcinoma diagnosed 4 
years earlier presented to his local neurosurgeon with 
left arm weakness. He had known cervical spondylotic 
radiculopathy that had been treated with an anterior 
cervical discectomy and fusion 1 year earlier by the same 
neurosurgeon. Cervical magnetic resonance imaging 
(MRI) did not reveal a cause for his weakness, but a brain 
MRI disclosed a 1-cm right frontal lesion [Figure 1]. 
The neurosurgeon performed a freehand biopsy via an 
open craniotomy, and the tissue sample was interpreted 
as gliosis by the pathologist. The patient was referred 
to our clinic for SRS, but since no tissue diagnosis had 
been established, a frameless stereotactic craniotomy was 
performed. Preoperative images demonstrated that the 
actual lesion was quite remote from the location of the 
craniotomy [Figure 2]. The lesion was identified and was 
histologically consistent with renal cell carcinoma. 
Precise intraoperative navigation is dependent 
on obtaining preoperative stereotactic MRI. The 
intraoperative imaging system must provide images 
with enough resolution to distinguish between tumor 
and normal brain and also between tumor and non-
tumor pathologies such as peritumoral edema.[25] 
Functional MRI (fMRI) and cortical mapping can be 
used to identify eloquent cortex both before and during 
surgery. These surgical adjuncts increase the accuracy 
of tumor localization, identify tumor margins, plan 
the optimal surgical trajectory, and minimize the size 
of the craniotomy needed for lesion removal. In the 
series presented in Table 1, these modalities were used 
occasionally, although not as frequently as in the case 
of primary brain tumors. One explanation for this is the 
more defined borders and histological differences between 
normal brain and metastatic tumors, which enabled more 
precise localization; however, when a lesion was located 
in an area near motor or speech function and the surgical 
approach appeared to require traversing normal brain 
tissue, fMRI and intraoperative cortical mapping were 
applied.
In a retrospective study of 150 patients with single and 
multiple brain metastases, Schackert et al.[19] showed that 
median survival time was prolonged in patients in whom 
neuronavigation was used (16 months vs. 10 months with 
a single metastasis, 11 months vs. 5 months with multiple 
lesions). Although these results were not statistically 
significant, the feasibility of resecting less accessible 
tumors in debilitated patients has increased with the use 
of intraoperative image guidance and neuronavigation. In 
our series, the overwhelming majority of cases (231/259, 
89%) were performed with this surgical adjuvant [Table 1]. 
Because we have no control group (non–image-guided 
surgery) against which to compare, we have no way of 
determining whether this approach has impacted patient 
outcome including progression-free survival and overall 
survival.
Image guidance not only results in less surgical morbidity 
and greater accuracy of resection, but also in less overall 
cost to the patient. A British study done in 2000 showed 
that in patients undergoing craniotomy for meningioma 
resection, the use of image guidance resulted in a 
Figure 2: The patient described in Figure 1 underwent a frameless 
stereotactic craniotomy using intraoperative surgical navigation. 
Preoperative axial T1-weighted gadolinium-enhanced MRIs 
demonstrating actual lesion (a), with prior surgical bed visible 
anterior to lesion (b). Coronal T1-weighted gadolinium-enhanced 
MRIs demonstrating actual lesion (c), with prior surgical bed visible 
anterior to lesion (d). Sagittal T1-weighted nonenhanced MRIs 
demonstrating actual lesion with prior surgical bed visible anterior 
to lesion (e) and actual surgical bed (f). The lesion was identified and 







Figure 1: A 67-year-old man with a history of renal cell carcinoma 
diagnosed 4 years earlier presented with left arm weakness. (a) Axial, 
(b) coronal, and (c) sagittal T1-weighted MRIs without gadolinium 
enhancement demonstrate a 1-cm right frontal enhancing lesion
a b c
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statistically significant decrease in surgical time as well 
as shorter duration of time in the intensive care unit 
(1.7 day vs. 1 day) and in overall length of hospital stay 
(13.5 days vs. 8.5 days).[16] Because of the added costs for 
prolonged hospitalization, these decreases translate to 
financial savings. Although we have not done a similar 
cost-effectiveness analysis, more accurate localization 
leading to complete removal of a metastatic lesion would 
a priori result in shorter time spent in the hospital and 
possibly decreased overall hospital costs. 
DISADVANTAGES
There is a learning curve involved in employing 
intraoperative neuronavigation, especially for 
neurosurgeons trained before its development; however, 
contemporarily trained neurosurgical residents are 
well versed in the use of image-guided neurosurgery. 
Although improvements can be difficult to quantify in 
a formal randomized controlled study, neuronavigational 
techniques have improved over time as increasingly 
sophisticated neuronavigational platforms are introduced 
and as practitioners become more versed in the world 
of high-speed computing. Initially, the time required to 
set up the navigational systems preoperatively increased 
operating room time; however, although we have not 
specifically measured this process, we believe that this 
set-up time has decreased over the years of using these 
systems. Of course, with each software upgrade or 
computer operating system change, or when using a new 
navigation platform, these issues can return even for the 
experienced surgeon. Nevertheless, the time saved by 
precise localization of the lesion before skin incision and 
the decreased time spent searching for a lesion makes up 
for the time spent setting up the case before beginning 
the actual operative procedure.
Perhaps the greatest limitation of neurosurgical image-
guided stereotactic lesion removal is intraoperative 
brain shift.[3] Brain shift can occur as a result of dural 
opening, the use of mannitol and hypertonic saline for 
brain relaxation and cerebrospinal fluid (CSF) drainage, 
or tumor resection itself. In fact, previous studies have 
shown that the brain can shift as much as 2.4 cm during 
tumor surgery.[10,11] This leads to inaccuracy in identifying 
tumor margins intraoperatively since the images used 
for neuronavigation are obtained prior to surgery. Other 
factors hypothesized to lead to intraoperative brain shift 
include increasing patient age (because of greater cerebral 
atrophy) and prior surgery or radiation (with scarring 
requiring increased brain manipulation).[3] Conversely, 
small tumor size (<30 cm3) has been shown to correlate 
with the success of tumor resection using image-guided 
stereotactic techniques, perhaps in part due to less 
brain shifts with smaller lesion size.[3] Therefore, while 
image-guided stereotactic techniques lead to increased 
accuracy of tumor resection and shorter hospital 
stays,[13] precautions must be undertaken to minimize 
intraoperative brain shifts, which can lead to incomplete 
tumor removal. 
Several techniques can be used during removal of 
malignant cerebral metastases to help prevent or 
minimize intraoperative brain shifts. These include 
avoiding brain contraction techniques, such as 
hyperventilation and mannitol administration, until the 
tumor is exposed and ready to be debulked. Eschewing 
CSF diversion whenever possible and tracing the tumor 
margins using neuronavigation prior to tumor resection 
may also help reduce the amount of brain shift, as will 
avoiding penetrating a tumoral cyst.[3] 
One potential method for correcting for intraoperative 
brain shift once it occurs is the use of intraoperative 
MRI (IMRI), an emerging technique that allows 
for intraoperative imaging and reregistration of the 
navigational system. The newly acquired image is done in 
the same position as the surgical position and any brain 
shifting from CSF loss or tumor removal is visualized 
in situ. This technology is not widely available, and its 
usefulness for neurosurgical procedures has not been 
fully quantified. Several studies have demonstrated its 
usefulness in primary brain tumors, especially low- and 
high-grade gliomas;[8,20,24] however, the utility of this 
technique is not as clear for metastatic disease. We 
have used this technology in a limited fashion but hope 
to further study this in the future. In our limited use, 
we have this illustrative case. A 67-year-old man with 
1-month history of confusion was found to have a large 
bifrontal mass that was thought to be a primary glioma 
rather than a metastatic tumor [Figure 3a]. Complete 
resection was obtained using intraoperative stereotactic 
navigation and confirmed with IMRI [Figure 3b]. A large 
Figure 3: A 67-year-old man with 1-month history of confusion 
was found to have a heterogeneously enhancing mass thought 
to represent a primary high-grade glioma or metastatic lesion. 
(a) T1-weighted SPGR MRI with gadolinium enhancement. 
(b) Intraoperative T1-weighted SPGR MRI with gadolinium 
enhancement showing a noticeable amount of brain shift that would 
have rendered the original navigational MRI inaccurate
a b
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amount of brain shift was noted in the supine position 
in a bifrontal craniotomy that would have rendered the 
original navigational MRI inaccurate in the anterior–
posterior direction. By transferring the intraoperative 
image to the neuronavigational system during surgery, 
any residual tumor would have been very straightforward 
to remove at that time.
TUMOR LOCATION AND SELECTION
When image guidance is used, both mean hospital stay 
and overall survival are similar in patients with single 
and multiple metastatic lesions, with no increase in 
perioperative complications.[12] These data imply that 
patients with multiple accessible tumors should no 
longer be excluded from surgical consideration. This 
is especially true in patients with symptomatic lesions 
with controlled systemic disease. Surgery is particularly 
important in patients for whom there is no identifiable 
primary tumor. As mentioned in the case described 
in Figure 1, neuronavigation is especially important 
when tissue diagnosis is the primary goal of the surgery. 
Nondiagnostic biopsies lead to more procedures with 
more chance for complications. An even worse scenario is 
a resection of tissue on the edge of the metastatic lesion 
that is interpreted as gliosis or low-grade astrocytoma, 
leading to a completely wrong treatment algorithm. 
The use of neuronavigation with metastatic tumors in 
the posterior fossa is more controversial. Although we 
have used image-guided surgical techniques for many 
cerebellar lesions, it is somewhat less helpful in certain 
situations. First, given the small size of the posterior 
fossa and the well-defined borders of the tentorium and 
convexity dura, neuronavigation is not always necessary. 
Second, the prone position used in these surgeries can 
make access to external landmarks and fiducial markers 
more difficult than in supratentorial cases. Nevertheless, 
for deep-seated lesions of the posterior fossa, especially 
those near cerebellar nuclei, brainstem, or brachium 
pontis, neuronavigation may prove helpful and possibly 
even indispensable.
While gross total resection is desirable, many metastatic 
lesions have poorly defined borders and infiltrate into 
surrounding normal brain, so judgment must be exercised 
to avoid damaging the surrounding eloquent structures. 
Metastatic lesions, especially those treated with SRS, 
often show a mixture of radiation changes in the 
surrounding brain, necrotic tumor areas, and nests of live 
tumor cells. This is a situation where neuronavigation 
can help guide the surgeon to differentiate tumor from 
normal brain. This is also a situation in which IMRI may 
prove useful. 
Neuronavigation is perhaps most useful for tumors 
located in eloquent cortex because critical structures can 
be avoided with precise lesion localization. The navigation 
system is indispensable in the operating room but may 
be even more important before the operative procedure 
begins. We routinely plan surgical approaches to avoid 
eloquent cortex using the anatomical data supplied by 
the preoperative MRI in the treatment planning station. 
Additionally, by using diffusion-weighted imaging with 
cortical tractography, fMRI, and positron emission 
tomography (PET) images loaded into the navigation 
system and fused to the anatomical data set, surgical 
plans can be made to minimize risk and maximize tumor 
resection. In addition, if the primary tumor is known, the 
surgeon should be aware of those lesions that have a high 
tendency to hemorrhage, including melanoma and renal 
cell tumors.[21] In these situations, it might be considered 
desirable to circumferentially dissect the tumor from the 
surrounding brain and disrupt blood supply to the tumor. 
Image guidance would allow for identification of the 
tumor without entering the tumor capsule and could aid 
in this type of surgical approach.
Along these same lines, there are reports that piecemeal 
resection of a supratentorial brain metastasis carries a 
higher risk of leptomeningeal disease (LMD) than en 
bloc resection or SRS.[22,23] Patients with LMD have 
also been shown to have a worse overall prognosis.[21] 
This concept of increased risk of LMD after piecemeal 
resection is largely theoretical, and how it relates to 
patient outcome, including progression-free and overall 
survival, is unknown. Nevertheless, one could make the 
case that neuronavigation used as a surgical adjuvant 
could improve a surgeon’s ability to achieve an en bloc 
resection of a metastatic tumor and avoid the piecemeal 
approach to tumor removal. 
IMAGE GUIDANCE TECHNIQUE
All patients scheduled to undergo craniotomy for 
resection of cerebral metastases undergo stereotactic brain 
imaging with fiducial markers. Since almost all metastatic 
tumors enhance after administration of contrast agent, a 
T1-weighted, three-dimensional spoiled gradient recalled 
(SPGR) acquisition in a steady state with gadolinium 
contrast is our image of choice. Stereotactic computed 
tomography with contrast can be used for cases in 
which an MRI is not possible. For patients with severe 
renal failure, MRI without contrast is used, but this may 
require acquiring both a T1-weighted SPGR without 
contrast and a stereotactic T2-weighted MRI. In this 
situation, we fuse the two images and use them to best 
define the tumor borders. The fiducial markers are a 
luxury that can reduce registration time in the operating 
room and theoretically improve accuracy; however, when 
there is a delay between acquiring the preoperative 
imaging and the surgical procedure, external anatomical 
landmarks such as the medial and lateral canthi, pinna 
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or tragus of the ear, tip of the nose, nasion, and any prior 
surgical scars can all act as registration fiducials.
This imaging is then loaded onto the image guidance 
system either remotely through the hospital network 
or from a compact disc prepared by the radiology 
department. We routinely load the images and plan the 
surgical approach the evening before surgery or while 
the operating room is being prepared on the morning 
of surgery. Once in the operating room, the patient is 
placed in the Mayfield head holder and secured in place 
using three-point fixation. When we are using IMRI, a 
special head holder and a navigation localizer are used. 
The techniques for IMRI are described elsewhere and are 
outside the scope of this report.[8,20] Each fiducial marker, 
or anatomical landmark, is then registered as a surface 
landmark, and a non-sterile imaging probe is used to mark 
out the borders of the lesion to be resected to plan the 
surgical incision. We prefer linear incision when possible 
or “lazy S” or gentile curvilinear incision when required. 
The hair over the incision is covered with a mixture of 
Betadine and surgical lubricant, and the hair is parted 
over the planned incision; this allows for minimal or no 
hair removal. The planned incision is infiltrated with 
1% Marcaine, and preoperative antibiotics and steroids 
are administered. After the craniotomy is performed, 
a sterile guidance probe can be traced over the dura to 
ensure that the correct trajectory is taken. At this point, 
intraoperative brain shift can be avoided by withholding 
the use of hypertonic saline and mannitol if the dura is 
not tense. The dura is usually opened in a cruciate fashion 
to allow for extension at this operation or in subsequent 
future procedures. The image guidance system is used to 
plan a trajectory, and once the tumor is visualized, the 
resection borders can be rechecked periodically using the 
navigation probe. Once the resection is complete, the 
dura is closed and the bone flap is replaced in a standard 
fashion. The fiducials are removed at the end of the case, 
and our practice is to perform an MRI with contrast 
enhancement on postoperative day 1 to evaluate the 
resection and to ensure that there are no postoperative 
complications.
OUTCOMES
Our experience with over 750 craniotomies using image-
guided navigation, including roughly 200 for metastatic 
disease, has been one of improved extent of resection 
and less damage to surrounding eloquent structures. 
Others have reported similar results. In a review of 
54 patients who underwent image-guided resection of 
malignant brain tumors (9 metastatic, 45 high-grade 
gliomas), 47 patients successfully underwent tumor 
resection.[3] Although 11/47 patients had residual tumor 
on MRI, in 2 of these cases the tumor was purposely 
left behind because of the proximity to eloquent cortex 
such as the motor strip, in 2 cases frozen specimen 
revealed radiation necrosis, and in 7 cases the tumor 
was deliberately left behind to conform with a gene 
therapy trial. In this study,[3] tumor size correlated with 
successful resection, as larger tumors (>30 cm3) were 
less likely to be completely resected, possibly because 
of brain shifts causing inaccuracy with intraoperative 
localization. Our experience with metastatic disease 
suggests that especially in those patients not previously 
treated, larger lesions are usually fairly straightforward to 
completely resect. Smaller lesions, especially those of ≤1 
cm, are the cases in which intraoperative neuronavigation 
is invaluable. In addition, studies have shown that 
patient age, prior surgery or radiation therapy, and 
periventricular location do not affect surgical outcomes.[3] 
Prior studies, however, have shown that periventricular 
location can lead to intraoperative brain shifts during 
resection because of disruption of CSF dynamics, which 
can result in an incomplete resection.[2] We routinely 
use neuronavigation to avoid entering the ventricles in 
an effort to maintain normal CSF pathways and avoid 
introducing blood into the ventricular system. Overall, 
the use of image guidance has shown a clear benefit 
as an aid in the resection of malignant brain tumors, 
including metastatic lesions. Metastatic lesions remain 
especially challenging since they often infiltrate into 
adjacent normal brain and can be difficult to remove 
without resulting in neurologic compromise. Therefore, 
intraoperative imaging techniques are vital to maximize 
resection and minimize the risk of neurologic injury. 
CONCLUSION
Advances in the early diagnosis and treatment of various 
types of malignancies, while leading to greater life 
expectancy in those affected, have also resulted in a higher 
number of cerebral metastases. The use of intraoperative 
image guidance techniques enables the location and 
definition of cerebral metastases, leading to smaller 
craniotomies, less patient morbidity, and more accurate 
surgical resection. However, intraoperative imaging is not 
without pitfalls, the most significant being intraoperative 
brain shifts during resection, which can lead to 
inaccuracy in defining tumor boundaries. Future studies 
are needed with larger patient numbers to prospectively 
determine success of resection among patients with 
cerebral metastases using image guidance versus those 
in which imaging is not used. Additionally, studies that 
quantify the amount of brain shift intraoperatively 
and then correlate this shift with the extent of surgical 
resection would be useful to determine the exact effects 
of these changes on surgical outcome. Regardless, the 
use of image guidance is vital in the successful resection 
of cerebral metastases, and we recommend its use in all 
cases of metastatic lesion removal to maximize resection 
and minimize patient morbidity.
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